Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › AR › STUTTGART › BAPTIST HEALTH HOSPITALS

BAPTIST HEALTH HOSPITALS

NPI: 1790773158 · STUTTGART, AR 72160 · Rehabilitation Clinic/Center · NPI assigned 10/10/2005

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WELLS, TROY controls 20+ related entities in our dataset. Read more

$2.97M
Total Medicaid Paid
212,309
Total Claims
180,073
Beneficiaries
163
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWELLS, TROY (PRESIDENT)
NPI Enumeration Date10/10/2005

Related Entities

Other providers sharing the same authorized official: WELLS, TROY

ProviderCityStateTotal Paid
BAPTIST HEALTH REGIONAL HOSPITALS FORT SMITH AR $17.49M
BAPTIST HEALTH LITTLE ROCK AR $16.48M
BAPTIST HEALTH NORTH LITTLE ROCK AR $14.02M
BAPTIST HEALTH ARKADELPHIA AR $4.82M
CONWAY COMMUNITY SERVICES CONWAY AR $4.12M
BAPTIST HEALTH HEBER SPRINGS AR $3.69M
BAPTIST HEALTH LITTLE ROCK AR $2.93M
BAPTIST HEALTH MALVERN AR $2.68M
BAPTIST HEALTH REGIONAL HOSPITALS VAN BUREN AR $2.46M
BAPTIST HEALTH LITTLE ROCK AR $1.83M
BAPTIST HEALTH ARKADELPHIA AR $1.51M
BAPTIST HEALTH HOSPITALS STUTTGART AR $901K
BAPTIST HEALTH LITTLE ROCK AR $780K
BAPTIST HEALTH NORTH LITTLE ROCK AR $411K
BAPTIST HEALTH MONTICELLO AR $367K
BAPTIST HEALTH CONWAY AR $142K
BAPTIST HEALTH LITTLE ROCK AR $88K
BAPTIST HEALTH PRESCOTT AR $33K
BAPTIST HEALTH MALVERN AR $31K
BAPTIST HEALTH HEBER SPRINGS AR $22K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 27,650 $283K
2019 36,130 $374K
2020 30,730 $393K
2021 36,276 $564K
2022 36,500 $619K
2023 26,554 $435K
2024 18,469 $306K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 3,889 3,320 $324K
80053 Comprehensive metabolic panel 14,592 12,710 $228K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 6,521 1,690 $218K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1,679 1,534 $177K
70450 Computed tomography, head or brain; without contrast material 1,965 1,754 $153K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 7,894 6,897 $152K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 4,190 3,702 $137K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 8,901 8,013 $102K
80050 General health panel 2,307 2,149 $98K
74177 Computed tomography, abdomen and pelvis; with contrast material 808 710 $93K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 16,813 14,522 $87K
80048 Basic metabolic panel (calcium, ionized) 5,004 4,251 $87K
71046 Radiologic examination, chest; 2 views 4,041 3,631 $64K
80061 Lipid panel 5,805 5,390 $53K
36415 Collection of venous blood by venipuncture 9,804 8,300 $38K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 4,493 3,765 $36K
83036 Hemoglobin; glycosylated (A1C) 4,808 4,516 $33K
73560 1,500 1,339 $33K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,573 1,460 $31K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 290 272 $30K
84443 Thyroid stimulating hormone (TSH) 4,726 4,386 $29K
74176 Computed tomography, abdomen and pelvis; without contrast material 479 443 $29K
81025 3,276 2,937 $27K
71045 Radiologic examination, chest; single view 3,789 3,285 $26K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 712 639 $25K
83880 1,902 1,662 $25K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 3,279 2,825 $22K
87088 2,769 2,438 $22K
87800 849 754 $20K
81001 6,825 6,010 $20K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,062 1,827 $20K
84484 3,388 2,664 $20K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 419 382 $19K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 419 382 $19K
74018 1,085 992 $19K
77067 Screening mammography, bilateral, including computer-aided detection 373 364 $17K
87428 248 235 $17K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 178 159 $15K
80305 1,255 1,124 $15K
87420 1,267 1,161 $15K
87631 206 187 $14K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 719 656 $14K
72100 700 629 $14K
97161 260 228 $13K
82550 3,268 2,673 $13K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 345 299 $13K
85027 2,674 2,354 $13K
82607 1,214 1,136 $12K
81003 5,141 4,621 $12K
87077 1,261 1,150 $12K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 5,887 5,130 $11K
73030 565 484 $9K
80081 95 92 $9K
83605 1,135 974 $9K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 248 175 $9K
96361 Intravenous infusion, hydration; each additional hour 713 554 $8K
83735 1,953 1,485 $8K
87086 Culture, bacterial; quantitative colony count, urine 1,005 875 $8K
83690 1,381 1,221 $8K
87040 952 593 $7K
73630 310 277 $7K
80076 582 521 $7K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 151 135 $7K
96375 Therapeutic injection; each additional sequential IV push 1,114 984 $6K
73610 348 308 $6K
82150 1,023 904 $5K
84702 618 516 $5K
80306 262 226 $5K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 28 27 $5K
99283 Emergency department visit for the evaluation and management, moderate severity 787 720 $4K
86901 487 438 $4K
82962 868 509 $4K
87807 392 346 $4K
73130 165 151 $4K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 871 741 $4K
85610 1,654 1,360 $4K
J2405 Injection, ondansetron hydrochloride, per 1 mg 2,258 1,846 $3K
71020 270 252 $3K
74019 141 134 $3K
86900 487 438 $3K
87186 566 511 $3K
84153 356 331 $3K
86803 195 169 $3K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 1,008 847 $3K
82728 199 182 $3K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,285 1,116 $2K
85379 275 260 $2K
84439 311 274 $2K
73110 115 106 $2K
72125 Computed tomography, cervical spine; without contrast material 12 12 $2K
86592 798 750 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg 2,641 2,249 $2K
83540 336 308 $2K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 15 15 $2K
93975 32 25 $2K
83550 188 175 $2K
86780 96 83 $2K
82947 221 130 $2K
85007 731 650 $1K
82077 86 80 $1K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 174 155 $1K
71010 211 181 $1K
74022 53 45 $1K
99284 Emergency department visit for the evaluation and management, high severity 896 830 $1K
74000 68 57 $864.52
80320 47 37 $813.22
84550 239 223 $774.44
80074 13 12 $750.62
87400 73 64 $634.64
73502 37 25 $631.90
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 29 26 $560.43
97001 20 15 $540.15
82677 18 16 $483.56
77063 Screening digital breast tomosynthesis, bilateral 26 26 $464.22
87081 55 50 $458.49
85730 131 106 $449.26
82803 25 24 $429.37
86850 415 377 $411.89
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 17 12 $355.48
82105 18 16 $335.30
T1015 Clinic visit/encounter, all-inclusive 33 25 $324.00
72040 20 13 $308.14
87340 183 165 $306.94
86336 18 16 $304.78
82570 47 46 $301.27
82565 33 27 $290.87
85018 118 102 $289.51
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 665 563 $285.99
0353U 173 158 $283.52
82397 18 16 $282.52
83655 15 15 $259.20
90715 12 12 $259.20
86762 139 127 $257.70
97032 139 38 $243.01
87808 17 17 $229.67
82043 26 26 $166.24
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 13 12 $122.41
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 57 43 $104.87
J3010 Injection, fentanyl citrate, 0.1 mg 134 104 $99.79
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 24 24 $91.98
82044 61 58 $65.78
81002 31 28 $62.22
87210 13 12 $62.22
85652 28 24 $46.42
81015 49 44 $46.31
0202U Oncology (prostate), multianalyte, gene expression profiling 228 221 $42.58
J1170 Injection, hydromorphone, up to 4 mg 187 159 $36.51
J2270 Injection, morphine sulfate, up to 10 mg 198 165 $30.42
85014 14 12 $20.28
J7120 Ringers lactate infusion, up to 1000 cc 205 163 $16.10
J2250 Injection, midazolam hydrochloride, per 1 mg 220 175 $8.95
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 3,036 2,613 $7.00
J7030 Infusion, normal saline solution , 1000 cc 1,948 1,515 $6.83
J7050 Infusion, normal saline solution, 250 cc 1,843 1,117 $5.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 305 253 $1.11
J2550 Injection, promethazine hcl, up to 50 mg 14 12 $0.65
36600 25 24 $0.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 41 41 $0.00
A9270 Non-covered item or service 1,175 322 $0.00
90686 16 15 $0.00
J2765 Injection, metoclopramide hcl, up to 10 mg 13 12 $0.00
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen 16 14 $0.00
G0103 Prostate cancer screening; prostate specific antigen test (psa) 13 12 $0.00